| Income Tax Disclosure [Text Block] |
A reconciliation of income taxes at statutory rates with the reported taxes is as follows:
| | | | December 31, 2025 | | | | December 31, 2024 | |
| | | | | | | | | | | | | | | | | |
| Loss before taxes for the year | | | | | | $ | (319,133 | ) | | | | | | $ | (327,360 | ) |
| Federal and State tax rate | | | | | | | 28 | % | | | | | | | 28 | % |
| | | | | | | | | | | | | | | | | |
| Expected income tax (recovery) | | | 28.0% | | | $ | (89,000 | ) | | | 28.0% | | | $ | (92,000 | ) |
| Effect of change in tax rates | | | 0.0% | | | | - | | | | (1.8)% | | | | 6,000 | |
| Adjustment to prior years provision | | | (0.3)% | | | | 1,000 | | | | 3.7% | | | | (12,000 | ) |
| Change in valuation allowance | | | (27.7)% | | | | 88,000 | | | | (29.9)% | | | | 159,000 | |
| | | | | | | | | | | | | | | | | |
| Total income taxes | | | | | | $ | - | | | | | | | $ | - | |
| | | | | | | | | | | | | | | | | |
| Current income tax | | | | | | $ | - | | | | | | | $ | - | |
| Deferred tax recovery | | | | | | $ | - | | | | | | | $ | - | |
The significant components of the Company’s deferred tax assets that have not been included on the consolidated statement of financial position are as follows:
| | | December 31, 2025 | | | December 31, 2024 | |
| | | | | | | | | |
| Research and development | | $ | 110,000 | | | $ | 179,000 | |
| Non-capital losses | | $ | 6,780,000 | | | $ | 6,934,000 | |
| | | | | | | | | |
| | | $ | 6,890,000 | | | $ | 7,113,000 | |
| Unrecognized deferred tax assets | | | (6,890,000 | ) | | | (7,113,000 | ) |
| Net deferred tax assets | | $ | - | | | $ | - | |
The significant components of the Company’s temporary differences, unused tax credits and unused tax losses that have not been included on the consolidated statement of financial position are as follows:
| | | 2025 | | | Expiry Date Range | | | 2024 | | | Expiry Date Range | |
| Temporary Differences | | | | | | | | | | | | | | |
| Research and development | | $ | 394,000 | | | No expiry date | | | $ | 642,000 | | | No expiry date | |
| Non-capital losses available for future periods | | $ | 24,228,000 | | | 2023 to indefinite | | | $ | 24,777,000 | | | 2023 to indefinite | |
| Canada | | $ | 16,655,000 | | | 2025 to 2037 | | | $ | 17,766,000 | | | 2025 to 2037 | |
| USA | | $ | 7,573 ,000 | | | No expiry date | | | $ | 7,011,000 | | | No expiry date | |
|